{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:41:45Z","timestamp":1785415305143,"version":"3.56.0"},"reference-count":32,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"publisher","award":["503\/1-152-01\/503-11-001"],"award-info":[{"award-number":["503\/1-152-01\/503-11-001"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"publisher","award":["503\/1-013-02\/503-11-001"],"award-info":[{"award-number":["503\/1-013-02\/503-11-001"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]},{"award":["503\/1-152-01\/503-11-001"],"award-info":[{"award-number":["503\/1-152-01\/503-11-001"]}],"id":[{"id":"https:\/\/ror.org\/02t4ekc95","id-type":"ROR","asserted-by":"publisher"}]},{"award":["503\/1-013-02\/503-11-001"],"award-info":[{"award-number":["503\/1-013-02\/503-11-001"]}],"id":[{"id":"https:\/\/ror.org\/02t4ekc95","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Vitiligo is a chronic autoimmune skin disorder characterized by progressive melanocyte loss and depigmented skin lesions, whose pathogenesis has been attributed to genetic and immunological factors. The aim of this exploratory study was to assess REL and IL2 gene expression and evaluate the relationship between the presence of their polymorphisms (rs6545836 and rs2069763) and susceptibility to vitiligo and disease symptoms. The study included 100 patients with vitiligo and 47 healthy controls matched for age and sex. Gene expression in peripheral blood mononuclear cells was assessed using real-time PCR and the \u0394\u0394CT method. Higher REL expression was noted in patients compared with controls (median RQ = 1.52 vs. 1.22), although the difference was not significant (p = 0.919). IL2 gene expression remained below the detection threshold in all analyzed samples. Significant differences in IL2 rs2069763 distribution was found between patients and controls (p = 0.0059, \u03c72 = 7.57, chi-square test; p_adj = 0.02636, Bonferroni correction), with the C allele being more frequent among vitiligo patients and the A allele showing a potential protective effect. Although the CC genotype was initially associated with increased disease risk, this association did not remain significant after correction for multiple comparisons. No significant association between REL rs6545836 and overall susceptibility to vitiligo was identified. Nevertheless, rs6545836 was associated with REL expression levels (Kruskal\u2013Wallis test, p = 0.0032; p_adj = 0.0096, Bonferroni correction). While the overall analysis indicated associations between REL rs6545836 and clinical severity indices (BSA, VES, and VASI), most subgroup associations lost significance after Bonferroni correction; the VASI only demonstrated an insignificant relationship (p_adj = 0.0729). The obtained findings suggest that IL2- and REL-related immune pathways influence vitiligo pathogenesis and clinical heterogeneity; however, these exploratory findings should be interpreted cautiously and require confirmation in studies with greater statistical power.<\/jats:p>","DOI":"10.3390\/ijms27115084","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:23:21Z","timestamp":1780622601000},"page":"5084","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of REL and IL2 and Their Polymorphisms in the Pathogenesis of Vitiligo\u2014Exploratory Genetic Association Study"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8041-1285","authenticated-orcid":false,"given":"Marcelina","family":"K\u0105dziela","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Lodz, Pl. Hallera 1, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9856-0764","authenticated-orcid":false,"given":"Monika","family":"Migdalska-S\u0119k","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Genetics, Biology and Medical Microbiology, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Doma\u0144ska-Senderowska","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Genetics, Biology and Medical Microbiology, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Kutwin","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Lodz, Pl. Hallera 1, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0882-1458","authenticated-orcid":false,"given":"Ewa","family":"Brzezia\u0144ska-Lasota","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Genetics, Biology and Medical Microbiology, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3698-960X","authenticated-orcid":false,"given":"Anna","family":"Wo\u017aniacka","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Lodz, Pl. Hallera 1, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: Mechanisms of Pathogenesis and Treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5826\/dpc.0401a15","article-title":"Review of The Pigmentary System: Physiology and Pathophysiology (2nd ed) by James J. Nordlund, Raymond E. Boissy, Vincent J. Hearing, et al","volume":"4","author":"Milette","year":"2014","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1007\/s00403-023-02661-y","article-title":"Association of vitiligo with multiple cutaneous and extra-cutaneous autoimmune diseases: A nationwide cross-sectional study","volume":"315","author":"Silverberg","year":"2023","journal-title":"Arch. Dermatol. Res."},{"key":"ref_4","first-page":"88","article-title":"The prevalence of autoimmune endocrine diseases in vitiligo patients","volume":"92","author":"Troshina","year":"2020","journal-title":"Ter. Arkhiv"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigment Cell Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/ng.3680","article-title":"Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants","volume":"48","author":"Jin","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng.2272","article-title":"Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo","volume":"44","author":"Jin","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/exd.14100","article-title":"Association study between vitiligo and autoimmune-related genes CYP27B1, REL, TNFAIP3, IL2 and IL21","volume":"29","author":"Martins","year":"2020","journal-title":"Exp. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1128\/MCB.00592-15","article-title":"Long-Range Transcriptional Control of the Il2 Gene by an Intergenic Enhancer","volume":"35","author":"Mehra","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Chen, F., Xu, L., Zhao, T., Xiao, X., Pan, Y., and Hou, S. (2016). Genetic Variation in the REL Gene Increases Risk of Behcet\u2019s Disease in a Chinese Han Population but That of PRKCQ Does Not. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0147350"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000506103","article-title":"Vitiligo: A Review","volume":"236","author":"Bergqvist","year":"2020","journal-title":"Dermatology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e16705","DOI":"10.1111\/jocd.16705","article-title":"Late-Onset Vitiligo: Epidemiology, Clinical Characteristics, and Management Strategies","volume":"24","author":"Hasan","year":"2025","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2310\/7750.2013.12075","article-title":"Effect of age at onset on disease characteristics in vitiligo","volume":"17","author":"Kanwar","year":"2013","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000354607","article-title":"Comorbidities associated with vitiligo: A ten-year retrospective study","volume":"227","author":"Sheth","year":"2014","journal-title":"Dermatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaad.2015.08.063","article-title":"Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study","volume":"74","author":"Gill","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1101\/gad.183434.111","article-title":"NF-\u03baB, the first quarter-century: Remarkable progress and outstanding questions","volume":"26","author":"Hayden","year":"2012","journal-title":"Genes Dev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.it.2013.01.004","article-title":"Regulation of nuclear factor-\u03baB in autoimmunity","volume":"34","author":"Sun","year":"2013","journal-title":"Trends Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Barnabei, L., Laplantine, E., Mbongo, W., Rieux-Laucat, F., and Weil, R. (2021). NF-\u03baB: At the Borders of Autoimmunity and Inflammation. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.716469"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2016.03.009","article-title":"Treating psoriasis by targeting its susceptibility gene Rel","volume":"165","author":"Fan","year":"2016","journal-title":"Clin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1089\/ars.2009.2779","article-title":"The Involvement of Smac\/DIABLO, p53, NF-kB, and MAPK Pathways in Apoptosis of Keratinocytes from Perilesional Vitiligo Skin: Protective Effects of Curcumin and Capsaicin","volume":"13","author":"Becatti","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7150\/ijbs.17318","article-title":"Novel approaches to vitiligo treatment via modulation of mTOR and NF-\u03baB pathways in human skin melanocytes","volume":"13","author":"Wan","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/labinvest.3780318","article-title":"Autoimmune Melanocyte Destruction in Vitiligo","volume":"81","author":"Pals","year":"2001","journal-title":"Lab. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2024.02.001","article-title":"Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer","volume":"57","author":"Shouse","year":"2024","journal-title":"Immunity"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/annrheumdis-2019-215396","article-title":"Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: A randomised, double-blind, placebo-controlled trial","volume":"79","author":"He","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0019-5154.92668","article-title":"Serum concentration of IL-6, IL-2, TNF-\u03b1, and IFN\u03b3 in Vitiligo patients","volume":"57","author":"Singh","year":"2012","journal-title":"Indian J. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1007\/s00125-024-06267-5","article-title":"Genetic evidence for efficacy of targeting IL-2, IL-6 and TYK2 signalling in the prevention of type 1 diabetes: A Mendelian randomisation study","volume":"67","author":"Kaiser","year":"2024","journal-title":"Diabetologia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.clim.2008.05.011","article-title":"G\/T polymorphism in the interleukin-2 exon 1 region among Han Chinese systemic lupus erythematosus patients in Taiwan","volume":"129","author":"Lin","year":"2008","journal-title":"Clin. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.clinre.2017.06.005","article-title":"Autoimmune hepatitis association with single nucleotide polymorphism of interleukin-2, but not interferon-gamma","volume":"42","author":"Yousefi","year":"2018","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.aller.2015.12.005","article-title":"Association of interleukin-2 and interferon-\u03b3 single nucleotide polymorphisms with Juvenile systemic lupus erythematosus","volume":"44","author":"Harsini","year":"2016","journal-title":"Allergol. Immunopathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jid.2022.10.021","article-title":"Comorbidities in Patients with Vitiligo: A Systematic Review and Meta-Analysis","volume":"143","author":"Lee","year":"2023","journal-title":"J. Investig. Dermatol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/5084\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:26:39Z","timestamp":1780622799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/5084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27115084"],"URL":"https:\/\/doi.org\/10.3390\/ijms27115084","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]}}}